These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 19167992)

  • 1. Plasma cytokine concentration changes induced by the antitumor agents dipterinyl calcium pentahydrate (DCP) and related calcium pterins.
    Moheno P; Pfleiderer W; Fuchs D
    Immunobiology; 2009; 214(2):135-41. PubMed ID: 19167992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine and IDO metabolite changes effected by calcium pterin during inhibition of MDA-MB-231 xenograph tumors in nude mice.
    Moheno P; Pfleiderer W; DiPasquale AG; Rheingold AL; Fuchs D
    Int J Pharm; 2008 May; 355(1-2):238-48. PubMed ID: 18272305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dipterinyl calcium pentahydrate on hepatitis B virus replication in transgenic mice.
    Moheno P; Morrey J; Fuchs D
    J Transl Med; 2010 Mar; 8():32. PubMed ID: 20356392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity and pharmacokinetic properties of ARS-interacting multi-functional protein 1 (AIMP1/p43).
    Han JM; Myung H; Kim S
    Cancer Lett; 2010 Jan; 287(2):157-64. PubMed ID: 19573982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-17E, a proinflammatory cytokine, has antitumor efficacy against several tumor types in vivo.
    Benatar T; Cao MY; Lee Y; Lightfoot J; Feng N; Gu X; Lee V; Jin H; Wang M; Wright JA; Young AH
    Cancer Immunol Immunother; 2010 Jun; 59(6):805-17. PubMed ID: 20012860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium pterin as an antitumor agent.
    Moheno PB; ; ;
    Int J Pharm; 2004 Mar; 271(1-2):293-300. PubMed ID: 15129997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit proliferation of estrogen receptor-negative breast cancer cells by activation of multiple pathways.
    Vanderlaag K; Su Y; Frankel AE; Grage H; Smith R; Khan S; Safe S
    Breast Cancer Res Treat; 2008 May; 109(2):273-83. PubMed ID: 17624585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of orally administered dipterinyl calcium pentahydrate on oral glucose tolerance in diet-induced obese mice.
    Nikoulina SE; Fuchs D; Moheno P
    Diabetes Metab Syndr Obes; 2012; 5():43-7. PubMed ID: 22419880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
    O'Malley BW; Li D; McQuone SJ; Ralston R
    Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium-pterin suppresses mitogen-induced tryptophan degradation and neopterin production in peripheral blood mononuclear cells.
    Winkler C; Schroecksnadel K; Moheno P; Meerbergen E; Schennach H; Fuchs D
    Immunobiology; 2006; 211(10):779-84. PubMed ID: 17113915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic-pharmacodynamic modeling of biomarker response and tumor growth inhibition to an orally available heat shock protein 90 inhibitor in a human tumor xenograft mouse model.
    Yamazaki S; Nguyen L; Vekich S; Shen Z; Yin MJ; Mehta PP; Kung PP; Vicini P
    J Pharmacol Exp Ther; 2011 Sep; 338(3):964-73. PubMed ID: 21680888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of anti-tumor immunity by lipoteichoic acid-related molecule isolated from OK-432, a streptococcal agent, in athymic nude mice bearing human salivary adenocarcinoma: role of natural killer cells.
    Okamoto M; Ohe G; Furuichi S; Nishikawa H; Oshikawa T; Tano T; Ahmed SU; Yoshida H; Moriya Y; Matsubara S; Ryoma Y; Saito M; Sato M
    Anticancer Res; 2002; 22(6A):3229-39. PubMed ID: 12530069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanoma differentiation-associated gene-7 (mda-7)/interleukin (IL)-24 induces anticancer immunity in a syngeneic murine model.
    Miyahara R; Banerjee S; Kawano K; Efferson C; Tsuda N; Miyahara Y; Ioannides CG; Chada S; Ramesh R
    Cancer Gene Ther; 2006 Aug; 13(8):753-61. PubMed ID: 16543916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines.
    Glinsky GV; Price JE; Glinsky VV; Mossine VV; Kiriakova G; Metcalf JB
    Cancer Res; 1996 Dec; 56(23):5319-24. PubMed ID: 8968076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of orally bioavailable farnesyltransferase inhibitor, ABT-100, is mediated by antiproliferative, proapoptotic, and antiangiogenic effects in xenograft models.
    Ferguson D; Rodriguez LE; Palma JP; Refici M; Jarvis K; O'Connor J; Sullivan GM; Frost D; Marsh K; Bauch J; Zhang H; Lin NH; Rosenberg S; Sham HL; Joseph IB
    Clin Cancer Res; 2005 Apr; 11(8):3045-54. PubMed ID: 15837760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo.
    Matsumoto G; Namekawa J; Muta M; Nakamura T; Bando H; Tohyama K; Toi M; Umezawa K
    Clin Cancer Res; 2005 Feb; 11(3):1287-93. PubMed ID: 15709200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts.
    Chen P; Cameron R; Wang J; Vallis KA; Reilly RM
    J Nucl Med; 2003 Sep; 44(9):1469-78. PubMed ID: 12960194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic inflammatory response to exhaustive exercise. Cytokine kinetics.
    Suzuki K; Nakaji S; Yamada M; Totsuka M; Sato K; Sugawara K
    Exerc Immunol Rev; 2002; 8():6-48. PubMed ID: 12690937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in inflammatory mediators following eccentric exercise of the elbow flexors.
    Hirose L; Nosaka K; Newton M; Laveder A; Kano M; Peake J; Suzuki K
    Exerc Immunol Rev; 2004; 10():75-90. PubMed ID: 15633588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.